日韩成人一区二区三区在线观看,亚洲爆乳成av人在线视菜奈实,一级特黄aaa大片在线观看成人一级片在线观看,欧美一级a视频在线观看,久久综合狠狠色综合伊人,国产亂倫近親相姦视频,日韩免费无码视频一区二区三区,97久久精品亚洲中文字幕无码,久爱无码精品免费视频,超碰97人人模人人爽人人

Vaccine
Home > Application > Vaccine > Virus-like particle (VLP) vaccine

Virus-like particle (VLP) vaccine


Most currently available vaccines are mainly based on inactivated or attenuated live vaccines. Although these traditional vaccines have been used effectively against various infectious diseases, some of them have several limitations, including low likelihood of inducing a stronger immune response and their poor efficacy. Recent outbreaks of infectious diseases demonstrate the need to develop robust vaccines to overcome these limitations. The main challenge is to develop new technical approaches and boost immunity without compromising safety, efficacy and tolerability. Recent advances in vaccines based on DNA, mRNA, and recombinant viral vectors provide effective vaccine development methods for difficult-to-target pathogens and control infectious disease outbreaks.

 

Virus-like particle (VLP) technology provides an alternative platform for the development of effective vaccines against serious infectious diseases, and it is being developed in parallel with vaccines based on mRNA and viral vectors. VLPs are also much more immunogenic than other subunit vaccines because they present repetitive epitopes on their surface, making them more reliably detectable by the immune system. On the other hand, subunit vaccines may be less immunogenic due to misfolding of the target antigen or insufficient presentation to the immune system, and moreover, they require adjuvants and repeated vaccinations to elicit an adequate immune response. The term virus-like particle was first described by Fraenkel-Conrat and Williams (1955) by recombining tobacco mosaic virus (TMV) particles from purified RNA and protein components. The potential of these nanostructures to induce potent immune responses was then further investigated. The VLP platform can overcome various problems typically associated with traditional vaccines; specifically, infectivity, reversion to virulent forms, mutation risk associated with live attenuated vaccines, and reduced immunogenicity, toxicity instability, low yield and long formulation time associated with inactivated vaccines.

 

These bio-inspired nanostructures feature repetitive and high-density antigens from different viruses, helping to trigger a strong immune response. Furthermore, these highly immunogenic molecules possess the self-assembling properties of viral proteins. They are biocompatible and have the potential for structural flexibility during synthesis. They can be chemically or genetically modified and exhibit increased stability, uniformity, and functionality, and are considered effective tools in various biomedical applications. Depending on the presence or absence of a lipid membrane, VLPs can be classified as either enveloped or nonenveloped.

 

However, some of the key challenges associated with VLPs are low stability, difficult downstream processes, high production costs, and sensitivity to environmental conditions. Many different VLPs have been synthesized in various expression systems, such as bacteria, yeast, mammalian cells, insect cells, and plants. VLP-based vaccines have the potential to be used to treat various infectious diseases, including HIV, influenza, hepatitis B, hepatitis E, malaria, Ebola virus, SARS-CoV-2, Zika virus, dengue fever, and foot-and-mouth disease, among others. Several VLP-based vaccines have been licensed and marketed, including Engerix-B? and Recombivax HB? for HBV, Gardasil? and Cervarix? for HPV, Hecolin? for HEV, and Mosquirix? for malaria.


Related Products
Contact Us
  • Tel.: +86 021 6434 0155
  • E-Mail: marketing@duoningbio.com
  • Address: Building 30, No. 1525 Minqiang Road, Songjiang District, Shanghai
Message

Copyright ? Shanghai Duoning Biotechnology Co., Ltd. All Rights Reserved Sitemap | Technical Support: Reanod

WeChat
WeChat

Message-

Duoning Biotechnology

+86 021 6434 0155

精品国产高清三级在线观看| 成人毛片一区二区三区av9毛片| 亚洲中国久久精品无码| 伊人久久大香线焦AV综合影院| 国产欧美精品一区二区色综合| 91精品国产福利在线观看| 国产精品无码亚洲字幕资不卡| 性欧美暴力猛交在线播放| 亚洲精品97久久中文字幕无码| 成熟丰满熟妇高潮XXXXX| 三区18人妻少妇久久中文字幕| 黄色网站在线观看视频| 制服丝袜国产日韩一区| 丰满爆乳少妇中文无码| 亚洲国产精品免费无码| 99久久精品国产免费看不卡| 狠狠综合久久久久尤物| 视频一区二区美女引诱| 亚洲尹人香蕉网在线视颅| 国产福利电影一区二区三区| 国产午夜精品视频一区二区三区| 亚洲精品人成无码中文毛片| 久久精品国产亚洲AV无码麻豆| 少妇人妻无码精品视频app| 国产一本大道香蕉综合| 国产乱码一区二区三区| 免费无码国产V片在线观看| 波多野结衣一区二区三区高清| 国产中文区四暮区2021| 国产AV无码专区亚洲A∨毛片| 文视频欧美黑人又粗又大久久久| 国产欧美日韩综合精品二区| 免费男同亚洲精品中文字幕无码| 亚洲国产一区二区精品| 亚洲AV无码专区电影在线| 国产成人精品亚洲日本专区61| 精品国产成人一区二区| 国产V亚洲V天堂无码久久久| 亚洲另类自拍丝袜第1页| 亚洲中文无码h在线观看| 亚洲第一a在线观看网站|